206 related articles for article (PubMed ID: 19841539)
1. Homocysteine-mediated thrombosis and angiostasis in vascular pathobiology.
Loscalzo J
J Clin Invest; 2009 Nov; 119(11):3203-5. PubMed ID: 19841539
[TBL] [Abstract][Full Text] [Related]
2. Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis.
Jacovina AT; Deora AB; Ling Q; Broekman MJ; Almeida D; Greenberg CB; Marcus AJ; Smith JD; Hajjar KA
J Clin Invest; 2009 Nov; 119(11):3384-94. PubMed ID: 19841537
[TBL] [Abstract][Full Text] [Related]
3. Modulation of annexin II by homocysteine: implications for atherothrombosis.
Hajjar KA; Jacovina AT
J Investig Med; 1998 Oct; 46(8):364-9. PubMed ID: 9805420
[TBL] [Abstract][Full Text] [Related]
4. Regulation of fibrinolysis by S100A10 in vivo.
Surette AP; Madureira PA; Phipps KD; Miller VA; Svenningsson P; Waisman DM
Blood; 2011 Sep; 118(11):3172-81. PubMed ID: 21768297
[TBL] [Abstract][Full Text] [Related]
5. Annexin II regulates fibrin homeostasis and neoangiogenesis in vivo.
Ling Q; Jacovina AT; Deora A; Febbraio M; Simantov R; Silverstein RL; Hempstead B; Mark WH; Hajjar KA
J Clin Invest; 2004 Jan; 113(1):38-48. PubMed ID: 14702107
[TBL] [Abstract][Full Text] [Related]
6. The annexin A2 system and vascular homeostasis.
Flood EC; Hajjar KA
Vascul Pharmacol; 2011; 54(3-6):59-67. PubMed ID: 21440088
[TBL] [Abstract][Full Text] [Related]
7. Tissue plasminogen activator binding to the annexin II tail domain. Direct modulation by homocysteine.
Hajjar KA; Mauri L; Jacovina AT; Zhong F; Mirza UA; Padovan JC; Chait BT
J Biol Chem; 1998 Apr; 273(16):9987-93. PubMed ID: 9545344
[TBL] [Abstract][Full Text] [Related]
8. Modification of fibrinogen by homocysteine thiolactone increases resistance to fibrinolysis: a potential mechanism of the thrombotic tendency in hyperhomocysteinemia.
Sauls DL; Lockhart E; Warren ME; Lenkowski A; Wilhelm SE; Hoffman M
Biochemistry; 2006 Feb; 45(8):2480-7. PubMed ID: 16489740
[TBL] [Abstract][Full Text] [Related]
9. Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients.
Gugliucci A; Ghitescu L
Med Hypotheses; 2002 Sep; 59(3):247-51. PubMed ID: 12208147
[TBL] [Abstract][Full Text] [Related]
10. Influence of homocysteine on fibrin network lysis.
Lauricella AM; Quintana I; Castañon M; Sassetti B; Kordich L
Blood Coagul Fibrinolysis; 2006 Apr; 17(3):181-6. PubMed ID: 16575255
[TBL] [Abstract][Full Text] [Related]
11. Annexin II and regulation of cell surface fibrinolysis.
Hajjar KA; Acharya SS
Ann N Y Acad Sci; 2000 May; 902():265-71. PubMed ID: 10865846
[TBL] [Abstract][Full Text] [Related]
12. The annexin A2 system and angiogenesis.
Liu W; Hajjar KA
Biol Chem; 2016 Oct; 397(10):1005-16. PubMed ID: 27366903
[TBL] [Abstract][Full Text] [Related]
13. Annexin II: a mediator of the plasmin/plasminogen activator system.
Hajjar KA; Krishnan S
Trends Cardiovasc Med; 1999 Jul; 9(5):128-38. PubMed ID: 10639727
[TBL] [Abstract][Full Text] [Related]
14. Recombinant annexin II modulates impaired fibrinolytic activity in vitro and in rat carotid artery.
Ishii H; Yoshida M; Hiraoka M; Hajjar KA; Tanaka A; Yasukochi Y; Numano F
Circ Res; 2001 Dec; 89(12):1240-5. PubMed ID: 11739291
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia-inducible factor-1 drives annexin A2 system-mediated perivascular fibrin clearance in oxygen-induced retinopathy in mice.
Huang B; Deora AB; He KL; Chen K; Sui G; Jacovina AT; Almeida D; Hong P; Burgman P; Hajjar KA
Blood; 2011 Sep; 118(10):2918-29. PubMed ID: 21788340
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of homocysteine-induced atherothrombosis.
Lentz SR
J Thromb Haemost; 2005 Aug; 3(8):1646-54. PubMed ID: 16102030
[TBL] [Abstract][Full Text] [Related]
17. Endothelial cell annexin A2 regulates polyubiquitination and degradation of its binding partner S100A10/p11.
He KL; Deora AB; Xiong H; Ling Q; Weksler BB; Niesvizky R; Hajjar KA
J Biol Chem; 2008 Jul; 283(28):19192-200. PubMed ID: 18434302
[TBL] [Abstract][Full Text] [Related]
18. The Biology of Annexin A2: From Vascular Fibrinolysis to Innate Immunity.
Hajjar KA
Trans Am Clin Climatol Assoc; 2015; 126():144-55. PubMed ID: 26330668
[TBL] [Abstract][Full Text] [Related]
19. Reduced expression of annexin A2 is associated with impaired cell surface fibrinolysis and venous thromboembolism.
Fassel H; Chen H; Ruisi M; Kumar N; DeSancho M; Hajjar KA
Blood; 2021 Apr; 137(16):2221-2230. PubMed ID: 33512476
[TBL] [Abstract][Full Text] [Related]
20. Mesoglycan exerts its fibrinolytic effect through the activation of annexin A2.
Belvedere R; Morretta E; Pessolano E; Novizio N; Tosco A; Porta A; Whiteford J; Perretti M; Filippelli A; Monti MC; Petrella A
J Cell Physiol; 2021 Jul; 236(7):4926-4943. PubMed ID: 33284486
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
